Skip to content

Author

Moataz Ellithi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Safety Profile of Chimeric Antigen Receptor T-cell Therapies in Diffuse Large B-cell Lymphoma: An Analysis of Real-World Adverse Event Reporting From the FDA Adverse Event Reporting System

Objective To compare the real-world safety profiles of lisocabtagene maraleucel (liso-cel) and axicabtagene ciloleucel (axi-cel) in patients with diffuse large B-cell lymphoma, leveraging data from the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Patients and Methods Case...

Magdi Elsallab, M. Lunning, Moataz Ellithi et al. · 0 citations
Review Open access Sep 2026

Understanding and Mitigating the Risk of Accelerated Biological Aging in Survivors of Cancer: A Scoping Review

Cancer and its treatments are linked to accelerated biological aging, which may contribute to late adverse health outcomes in cancer survivors. This scoping review evaluated biomarker‐defined aging in adult cancer populations, focusing on associations with treatment exposures and the effectiveness of inter...

Moataz Ellithi, Emily Herdman, Danielle M. Westmark et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.